BENJAMIN L MARGOLIS, MD
Osteopathic Medicine in Ann Arbor, MI
License number
Michigan 4301065167
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Michigan 4301065167
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
1500 Floor Taubman Ctr, Ann Arbor, MI 48109
Phone
(734) 936-5548
(734) 936-2047
(734) 936-2047
Professional information
Benjamin L Margolis, Ann Arbor MI
Specialties:
Nephrologist
Address:
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
University of Manitoba, Faculty of Medicine - Doctor of Medicine
University Health Network-Toronto General Hospital - Fellowship - Nephrology (Internal Medicine)
University Health System - Residency - Internal Medicine
University Health System - Residency - Nephrology (Internal Medicine)
University Health Network-Toronto General Hospital - Fellowship - Nephrology (Internal Medicine)
University Health System - Residency - Internal Medicine
University Health System - Residency - Nephrology (Internal Medicine)
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Nephrology (Internal Medicine)
Dr. Benjamin L Margolis - MD (Doctor of Medicine)
Hospitals:
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical Schools
University Of Manitoba Faculty Of Medicine
Graduated: 1981
University Of Manitoba Faculty Of Medicine
Graduated: 1981
Expression-Cloning Method For Identifying Target Proteins For Eukaryotic Tyrosine Kinases And Novel Target Proteins
US Patent:
6391584, May 21, 2002
Filed:
Mar 29, 1999
Appl. No.:
09/280598
Inventors:
Joseph Schlessinger - New York NY
Edward Y. Skolnik - New York NY
Benjamin L. Margolis - Ann Arbor MI
Edward Y. Skolnik - New York NY
Benjamin L. Margolis - Ann Arbor MI
Assignee:
New York University Medical Center - New York NY
International Classification:
C07K 14705
US Classification:
435 691, 4352523, 4353201, 530350, 53038822, 536 235
Abstract:
The present invention relates to a novel method, based on direct expression cloning, for identifying target proteins capable of binding to and/or serving as substrates for receptor or cytoplasmic tyrosine kinases. The present invention also relates to novel proteins identified using this method, and to methods for identifying compounds that disrupt the interaction of such novel proteins with the receptor or cytoplasmic tyrosine kinases.